Dr. Reidenberg's current research is focussed on issues of general interest to clinical pharmacology. Some of these include: barriers to the use of opioids for treating pain, issues related to the World Health Organization Essential Medicines program, differences in individual patients' responses to a medication, and problems individualizing drug therapy.
Dr. Reidenberg's teaching activities focus on the teaching of clinical pharmacology to students at various levels in the College. His administrative activities include being Chairman of the Data Safety Monitoring Board and the Advanced Biomedical Science Committee. He is a member of the Medical Education Council and the Faculty Advisory Committee for the Students' Community Service Program. He is also Assistant Dean (Departmental Associates) and Program Chairman of the Departmental Associates of WMC.
Dr. Marcus Reidenberg had his medical and pharmacology training at Temple University. He served on the faculty there from 1962-1975 when he moved to Cornell. He has served as President of the American Society for Clinical Pharmacology and Therapeutics, as Chair of the Executive Committee of the Division of Clinical Pharmacology of the American Society for Pharmacology and Therapeutics, and as Chair of the Section of Clinical Pharmacology of the International Union of Pharmacology. He has served on advisory committees of the N.I.H. and F.D.A. and is a member of the World Health Organization Expert Advisory Panel on Drug Evaluation and has served on a number of W.H.O. Expert Committees including being elected Chairman of the WHO Expert Committee on the Selection and Use of Essential Medicines in 2007.
